Eir Ventures tops up life sciences fund with $138M for Nordic biotechs

Swedish venture capital manager Eir Ventures has rounded up a total of $138 million for its life sciences fund Eir Ventures I AB.

The fund — launched just last year — is the firm’s first dedicated life sciences venture capital fund, according to a company statement. Backed by a syndicate...

Click to view original post